The aim of this study was to determine whether pretreatment with alkalinised lignocaine reduced the incidence and severity of pain during propofol injection. This prospective, randomised, double-blind study included 300 adult, American Society of Anesthesiologists physcial status I to II patients undergoing elective surgery. Patients were randomly allocated to one of three groups: group l received 0.05 ml/kg of 1% lignocaine (5 ml normal saline + 5 ml 2% lignocaine), group A received 0.05 ml/kg alkalinised lignocaine (5 ml 2% lignocaine + 1 ml 8.4% NaHCO 3 + 4 ml normal saline), and group S, the control group, was given the same amount of normal saline (NaCl 0.9%). All drugs were given as a bolus over 20 seconds before propofol administration. A blinded researcher assessed the patient's pain level using a four-point scale. The pain score [median (range)] and the incidence of pain in group A (6%) was significantly lower than in groups l (41%) and S (88%, P <0.001). In addition, the pain score and the incidence of pain were found to be significantly different between group l and group S (P <0.001). The incidence of moderate and severe pain were greater in group S when compared with groups A and l (P <0.001). Intravenous pretreatment with alkalinised lignocaine appears to be effective in reducing the pain during propofol injection.
Approximately 70 to 90% of patients who receive propofol for anaesthesia induction experience pain during injection and this pain can be quite severe 1,2 . Many factors influence the incidence of this pain including the injection site, the size of the vein, injection speed, propofol temperature, speed of the intravenous carrier fluid and the use of local anaesthetics and opioids 3 . Various methods have been used to decrease propofol injection pain; these include the addition of lignocaine to propofol, the application of propofol at a different temperature or dilution, along with the adjuvant use of lignocaine, alfentanil, remifentanil, ondansetron, ephedrine, thiopentone ketamine or paracetamol prior to injection [4] [5] [6] [7] [8] [9] [10] [11] [12] . The most frequently used agent for propofol injection pain is intravenous lignocaine and the application of 0.5 mg/kg lignocaine via venous occlusion has been one of the the most effective methods 1, 13 . The use of lignocaine to decrease propofol injection pain is based on its presumed local anaesthetic effect on the vein 3 . However, lignocaine does not prevent pain effectively in approximately 40% of the patients treated in this manner 1 . The addition of sodium bicarbonate (NaHCO 3 ) to local anaesthetics accelerates both the intraneural diffusion of local anaesthetics and their penetration to the connective tissue around the nerve, thereby reducing the onset time and improving block quality 14, 15 . We hypothesised that alkalinisation of lignocaine would accelerate its local anaesthetic effect and thus further reduce propofol injection pain when used prior to the administration of propofol.
METHODS
The Ethics Committee of Inonu University Turgut Ozal Medical Centre, Malatya, Turkey approved this study (number 2011/A-207), and all patients provided written informed consent. This prospective, randomised, double-blind study (Clinical Trial Number NCT01773044) included 300 American Society of Anesthesiologists (ASA) physical status I to II patients aged between 18 and 60 years for whom elective surgery was planned with general anaesthesia. Exclusion criteria were communication difficulties, a history of allergy to the study drugs, a history of a suspicious or known difficult airway, and the use of opioid or nonsteroidal anti-inflammatory drugs within the past week.
Patients were assigned to one of three groups of 100 patients each by using computer-generated numbers as a simple randomisation method. group l was injected with 0.05 ml/kg of 1% lignocaine (Aritmal 2%, Osel Ilaç San. Tic. A.S, Istanbul, Turkey), (5 ml normal saline + 5 ml 2% lignocaine), group A with 0.05 ml/kg alkalinised lignocaine (5 ml 2% lignocaine + 1 ml 8.4% NaHCO 3 + 4 ml normal saline) (NaHCO 3 8.4%, DROgSAN Ilaç San. ve Tic. A.Ş, Ankara, Turkey) and Group S with the same amount of normal saline (NaCl 0.9%). A person who did not participate in the study prepared the study drugs in 10 ml injectors, and the syringes were labelled such that their contents could not be identified.
The pH values were measured with an NEl 890 pH meter. The pH of 1% lignocaine was 6.20, whereas the pH of lignocaine alkalinised by NaHCO 3 was 7.15.
Electrocardiogram, noninvasive arterial blood pressure and peripheral oxygen saturation (SpO 2 ) measurements along with standard monitoring techniques were used in the operating room. Patients did not receive preoperative medication. A 20-gauge intravenous cannula was placed on the dorsum of the non-dominant hand. The running carrier fluid was not started before the study drug was administered. We explained to the patients prior to anaesthetic induction that they might feel some pain in their arms due to the application of the intravenous anaesthetic. All drugs were prepared at room temperature just before application. The anaesthetist who administered the study drug was unaware of the identity of the solution that was being administered to each patient. To provide standardised venous occlusion, an automated blood pressure cuff was placed on the ipsilateral upper arm and programmed to inflate to venous puncture mode (continual 50 mmHg). The study drug was administered over a 20 second period after venous occlusion. The tourniquet was opened after 30 seconds.
Propofol (10 mg/ml ampoule, Fresenius, Turkey) was used at 2.5 mg/kg for anaesthetic induction. Patients received 25% of the calculated dose of propofol over five seconds. Another anaesthetist who did not know which study drug had been administered graded the pain using the fourpoint verbal rating scale published by McCrirrick and Hunter
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. The grading was as follows: 0 = no pain (negative response to questioning); 1 = mild pain (pain reported only in response to question without any behavioural signs); 2 = moderate pain (pain reported spontaneously, or in response to question, accompanied by a behavioural sign); and 3 = severe pain (strong vocal response or response accompanied by facial grimacing, arm withdrawal or tears).
Fentanyl (1 µg/kg) was applied after the propofol injection pain was graded. Anaesthetic induction was completed by the administration of the remaining propofol. Tracheal intubation was facilitated with 0.1 mg/kg vecuronium bromide. Anaesthesia was continued with desflurane 6.0 to 8.0% and 60% nitrous oxide in 40% O 2 .
An anaesthetist who was unaware of the patient's study group checked for the presence of pain, oedema, inflammation and allergic reactions at the injection area within 24 hours.
When assuming a pain incidence of 70% 12 after intravenous propofol injection and a difference of 11%, a power analysis with an alpha error of 0.05 and a beta error of 0.20 revealed that a minimum of 100 patients were required in each group (MedCalc Version 12.4.0.0 for Windows, MedCalc Software, Ostend, Belgium).
Statistical analyses were performed with SPSS version 21.0 (SPSS Inc., Chicago, USA). The results are expressed as the median values with min to max and frequencies with percentages. The data were tested using kolmogorov Smirnov test. Categorical variables were compared by using the Pearson chisquare test among the groups. The scores related to pain severity were compared by using the kruskalWallis H test. grading of pain (0: no pain, 1: mild pain, 2: moderate pain, 3: severe pain) was compared among the groups using the Pearson chisquare test. Multiple comparisons of the groups were performed by Mann Whitney U test with Bonferroni adjusted method. P values <0.05 were considered statistically significant.
RESUlTS
A total of 305 patients were included in the study. Three patients in group l, one in group A and one in group S were excluded from the study because of problems with difficult insertion of the cannula in a dorsal vein, leaving 100 in group l, 100 in group A and 100 in group S. The demographic data of the patients were similar across the groups (Table 1) .
The incidence and severity (as determined by pain scores) of pain during propofol injection in all groups are shown in Table 2 . The pain score [median (range)] and the incidence of pain in group A (6%) was significantly lower than in groups L (41%) and S (88%, P <0.001). In addition, statistically significant differences for the pain score and the incidence of pain were found between groups l and S (P <0.001). The incidence of moderate and severe pain were greater in group S when compared with groups A and l (P <0.001). In group A, the incidence of mild pain was significantly lesser than in groups l and S (P <0.001). The number of patients who experienced no pain were greater in group A than in groups l and S (P <0.001). In addition, the number of patients who experienced no pain were greater in group l than in group S (P <0.001).
Oedema, pain, wheal or flare response were not observed at the injection site or reported by any patients during the 24 hours after the operation.
DISCUSSION
In this study, we showed that alkalinised lignocaine was more effective than lignocaine alone or saline in reducing both the incidence and severity of propofol injection pain. To our knowledge, this is the first study showing that NaHCO 3 added to lignocaine decreases propofol injection pain. We hypothesise that the alkanisation of lignocaine accelerated local anaesthetic effect on the vein.
Propofol is a frequently used agent for the induction and maintenance of anaesthesia. However, the pain that occurs during injection causes discomfort for the patient 3 . Although the aetiology of propofol injection pain has not been clarified, two basic mechanisms have been proposed as the cause of injection pain. The first mechanism is the direct irritation of the skin, mucous membranes and venous intima due to the phenol groups contained in propofol 9 . The second mechanism is due to an indirect effect of propofol on the endothelium, whereby the kinin-kallikrein system is activated with a consequent increase in bradykinin formation. Bradykinin increases the contact of propofol with nerve endings of the vein and consequently increases the pain related to propofol injection 13, 16 . The incidence of propofol injection pain can increase up to 90% when the veins on the dorsum of the hand are used during anaesthetic induction 3 . Similarly, in our study, propofol injection pain was observed in 88% in the saline group when the veins on the dorsum of the hand were used.
Different methods have been used to decrease the incidence and severity of the pain caused by propofol injection. The most popular methods used to prevent propofol injection pain are the addition of lignocaine to propofol or pretreatment with lignocaine via bolus injection prior to propofol injection 3 . However, failure rates of 32 and 42% were reported even with these methods 10, 17 . The mechanism by which lignocaine prevents pain when applied prior to propofol injection is reported to be its local anaesthetic effect on the vein and its stabilisation of the kinin cascade 1 . It is thought that lignocaine forms a modified Bier block on the proximal forearm after its application via a tourniquet and this is thought to be the most effective method for preventing propofol injection pain 1,2 . In our study, a tourniquet was applied for a period of 30 seconds and the pain ratio with 0.5 mg/kg 1% lignocaine was 41%. This ratio is in accordance with results from previous studies 1, 2 . Increasing the pH of local anaesthetics by adding NaHCO 3 increases their onset speed and effectiveness. It has been shown in some studies that the alkalinisation of local anaesthetic with NaHCO 3 increases the quality (spread and duration) of the regional block and decreases onset time 14, 15, 18 . The pain-reducing effect of alkalinisation depends on the influence of the higher pH on the amounts of ionised and non-ionised forms of lignocaine. Because only the non-ionised form of lignocaine can infiltrate nerve membranes and interstitial tissues, the increase in the amount of the nonionised form with the addition of NaHCO 3 increases the effectiveness of the local anaesthetic 15 . The greater diffusability of the non-ionised form may result in rapid inhibition of pain transmission, thereby preventing nociceptive impulses from being fully appreciated 19 . It has been reported that the non-ionised form of lignocaine varies between less than 1 and 11% according to pH levels of the solution, when pH levels of solution vary between six and seven respectively. In our study, the incidence of propofol injection pain was 6% after the alkalinisation of lignocaine.
There are some limitations in the present study. First, we did not investigate the optimum dose of bicarbonate and further studies are warranted in this area. We used a ratio of one to ten since this was used in other studies carried out with lignocaine 14, 15, 20 . Second, it would have been better for the patients to report their own pain instead of an observer. When the pain was evaluated by the patient it could be more difficult to distinguish between mild and moderate pain 21 . The patient's assessment of pain may require some subjective scales (such as visual analog scale) and is not practical for use in a clinical setting 22 , so we used verbal rating scale as did previous studies 12, 23 . Third, recalled percieved pain postoperatively was not evaluated. Studies that have not used premedication demonstrated that there were no differences in the recall of propofol injection pain 24, 25 . We did not evaluate recall of propofol injection pain postoperatively because we felt that recall may not always be reliable.
In conclusion, intravenous pretreatment with alkalinised lignocaine appears to be effective in reducing both the incidence and severity of the pain during propofol injection when compared to both lignocaine alone and a saline placebo.
